Danny Rischin
丹尼·里辛
MBBS, MD, FRACP
Director, Division of Cancer Medicine; Head, Head and Neck Cancer Service肿瘤医学部主任；头颈部癌症科负责人
👥Biography 个人简介
Danny Rischin is Australia's most eminent head and neck cancer clinician-researcher, directing Peter MacCallum's cancer medicine division. He defined the superior prognosis of HPV-positive oropharyngeal cancer through TROG 02.02, established tirapazamine trials, and led KEYNOTE-689 evaluating perioperative pembrolizumab in resectable HNSCC.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
HPV-Positive HNSCC Prognostic Characterization
Led TROG 02.02 (HeadSTART) phase III trial that was among the first to demonstrate the dramatically superior outcomes of HPV/p16-positive oropharyngeal cancer with chemoradiotherapy, fundamentally redefining HNSCC risk stratification and trial design.
Perioperative Immunotherapy in Resectable HNSCC
Led KEYNOTE-689, a global phase III trial evaluating neoadjuvant and adjuvant pembrolizumab combined with standard-of-care therapy in resectable locally advanced HNSCC, investigating whether perioperative IO improves event-free survival.
Representative Works 代表性著作
Prognostic significance of p16INK4A and human papillomavirus in patients with oropharyngeal cancer treated on TROG 02.02 phase III trial
Journal of Clinical Oncology (2010)
Landmark analysis showing p16-positive oropharyngeal cancer patients had markedly improved 2-year overall survival (91% vs 74%), establishing HPV status as the dominant prognostic factor in HNSCC.
Tirapazamine, cisplatin, and radiation versus cisplatin and radiation for advanced squamous cell carcinoma of the head and neck: TROG 02.02 randomised trial
Journal of Clinical Oncology (2010)
Phase III trial of tirapazamine hypoxia-targeted radiosensitization in HNSCC; while primary endpoint was not met, generated critical insights into hypoxia biology and HPV-stratified outcomes.
🏆Awards & Recognition 奖项与荣誉
📄Data Sources 数据来源
Last updated: 2026-01-15 | All information from publicly available academic sources
Related Experts 相关专家
Brian Marples
University of Rochester Medical Center
Silvia C. Formenti
Weill Cornell Medicine / NewYork-Presbyterian Hospital
Paul M. Harari
University of Wisconsin School of Medicine and Public Health
Jeff Forman
Wayne State University / Karmanos Cancer Institute
关注 丹尼·里辛 的研究动态
Follow Danny Rischin's research updates
留下邮箱，当我们发布与 Danny Rischin（Peter MacCallum Cancer Centre, Melbourne）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment